Cite
Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial
MLA
Julian Gunn, et al. “Effect of Eplerenone in Percutaneous Coronary Intervention-Treated Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Subanalysis of the EPHESUS Trial.” European Journal of Heart Failure, vol. 16, Apr. 2014, pp. 685–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44d7524729a58c2f054e0af4cb0339e2&authtype=sso&custid=ns315887.
APA
Julian Gunn, Iain B. Squire, David Adlam, Renaud Fay, Yasir Parviz, Faiez Zannad, Bertram Pitt, & Javaid Iqbal. (2014). Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial. European Journal of Heart Failure, 16, 685–691.
Chicago
Julian Gunn, Iain B. Squire, David Adlam, Renaud Fay, Yasir Parviz, Faiez Zannad, Bertram Pitt, and Javaid Iqbal. 2014. “Effect of Eplerenone in Percutaneous Coronary Intervention-Treated Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Subanalysis of the EPHESUS Trial.” European Journal of Heart Failure 16 (April): 685–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44d7524729a58c2f054e0af4cb0339e2&authtype=sso&custid=ns315887.